Clinical Trials Browser

Phase NA × Active not recruiting × Non-Muscle Invasive Bladder Neoplasms × Clear all

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence

NCT07252297 2025-11-26

NMIBC

Phase NA Active not recruiting

177 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Disease

NCT04811846 2024-12-09

CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood

Phase NA Active not recruiting

40 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplastic Cells, Circulating, Neoplasms, Urogenital Neoplasms

NCT04167631 2024-10-30

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Phase NA Active not recruiting

150 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms

NCT05671900 2024-03-08

Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer

Phase NA Active not recruiting

70 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT04100733 2023-06-01

SEALS Xpert

Phase NA Active not recruiting

392 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Clinical Trials

CRUCIAL-R

NMIBC

CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer

SEALS Xpert